Incidence of TNS After Intrathecal Lidocaine v.s Bupivacaine (NCT03862287) | Clinical Trial Compass
UnknownNot Applicable
Incidence of TNS After Intrathecal Lidocaine v.s Bupivacaine
Canada160 participantsStarted 2018-11-01
Plain-language summary
This study will look into the incidence of Transient neurological symptoms (TNS) after the intrathecal use of lidocaine in comparison to intrathecal Bupivacaine.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ASA I-III male and female patients aged between 18 to 80 years old, who will receive spinal anesthesia for surgeries lasting less than one hour.
Exclusion Criteria:
* Patients younger than 18 years old.
* ASA physical status \>3.
* Immunosuppression or high risk of infection.
* Contraindications to receiving spinal anesthesia (e.g. coagulation impairment).
* Patients with psychosis
* Patients with preexisting back pain.
* Patients with cognitive impairment
* Allergies to local anesthetics, analgesics or any medication used in the study.
* Patients with chronic regular opioid usage
* Presence of preexisting neurological symptoms.
What they're measuring
1
Transient Neurological Symptoms
Timeframe: Day 1
2
Transient Neurological Symptoms
Timeframe: Day 3
Trial details
NCT IDNCT03862287
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre